Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib effectively treated a woman's severe symptoms from a rare autoimmune condition.

Tofacitinib is effective and safe for treating severe hair loss in Korean patients.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

Tofacitinib effectively improved hair regrowth and skin condition in a woman with alopecia totalis and lichen planus hypertrophicus.

4-(Ethoxycarbophenyl) retinamide is much less toxic than other retinoids.

Tofacitinib helped a man with alopecia totalis regrow all his hair.

Combining excimer lamp and tofacitinib gel may help treat hair loss in children.

New treatment for hair loss using special microneedles shows promise in reducing inflammation and promoting hair growth.

Topical PROTACs show promise for treating skin conditions but need better stability and delivery methods.

Anti-epileptic drugs may cause visual and hair side effects due to enzyme inhibition, especially in genetically predisposed individuals.

Using tacalcitol ointment with photodynamic therapy may effectively treat follicular mucinosis with scalp hair loss.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

An intact skin barrier is crucial to prevent infection in cases of tether-induced tenosynovitis.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

PPARγ signaling modulation can protect hair follicle stem cells from chemotherapy-induced damage.

Most European physicians know the risks and safe use of Cyproterone acetate, but few remember receiving official safety communications.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

The new gel formulation for Acitretin improves topical delivery and reduces oral toxicity.

Oral tofacitinib is a promising treatment for beard hair loss in alopecia areata.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Ethylenthiourea is toxic to the liver and nervous system, especially with alcohol.

Tofacitinib helped a woman with total-body hair loss grow her hair back.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Baricitinib was effective in treating severe and very severe alopecia areata after 52 weeks.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.